Improving testicular cancer pharmacotherapy through the use of pharmacogenomic approaches
0.3/100,000 inhabitants. It represents 1% of male neoplasms and 5% of urological tumors, with 3-10 new cases occurring per 100,000 males/per year. The most common subtypes of TCa are seminom and non-seminoma germ cell. Seminoma TCa represents about 30% t
| Autor: | |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2014 |
| País: | Chile |
| Idioma: | inglés |
| OAI Identifier: | oai:repositorio.anid.cl:10533/228658 |
| Acceso en línea: | https://hdl.handle.net/10533/228658 |
| Access Level: | acceso abierto |
| Sumario: | 0.3/100,000 inhabitants. It represents 1% of male neoplasms and 5% of urological tumors, with 3-10 new cases occurring per 100,000 males/per year. The most common subtypes of TCa are seminom and non-seminoma germ cell. Seminoma TCa represents about 30% t |
|---|